# Leveraging Telemedicine to Improve Guideline-Directed Medical Therapy Use and Outcomes Among Rural Patients With Heart Failure

Study · id `cardio:ct-nct07946679` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07946679](<https://clinicaltrials.gov/study/NCT07946679>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT07946679

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 600 participants.

## Technical summary

Registry record NCT07946679. Randomized; no masking; primary purpose treatment. Start 2026-12 (anticipated); primary completion 2031-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 600 participants (planned count; ClinicalTrials.gov record NCT07946679, source copy `cardio:ctgov-nct07946679-2026-11-18`, retrieved 2026-11-18)
- Planned start: 2026-12 (anticipated) (ClinicalTrials.gov record NCT07946679, source copy `cardio:ctgov-nct07946679-2026-11-18`, retrieved 2026-11-18)
- Primary completion: 2031-12 (anticipated) (ClinicalTrials.gov record NCT07946679, source copy `cardio:ctgov-nct07946679-2026-11-18`, retrieved 2026-11-18)
- Completion: 2031-12 (anticipated) (ClinicalTrials.gov record NCT07946679, source copy `cardio:ctgov-nct07946679-2026-11-18`, retrieved 2026-11-18)
- Countries: United States (ClinicalTrials.gov record NCT07946679, source copy `cardio:ctgov-nct07946679-2026-11-18`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07946679-2026-11-18`, retrieved 2026-11-18)

## The registry's words

- Brief title: Leveraging Telemedicine to Improve Guideline-Directed Medical Therapy Use and Outcomes Among Rural Patients With Heart Failure
- Acronym: RURAL-HF
- Condition: Heart Failure
- Condition: Heart Failure Hospitalization
- Intervention (Other): Provider-to-provider telehealth GDMT titration support
- Intervention (Device): Cellular-connected remote patient monitoring
- Lead sponsor: University of Michigan
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry lists this organization as the lead sponsor: University of Michigan (`cardio:org-university-of-michigan`)

## Provenance

Content hash: 729c8b32fd86c959143fc4e08fa7efff16d39d11b60ca5e92ab86502da3b7709
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
